Phase II study of gemcitabine in ovarian cancer. | Ann Oncol;10(7): 853-5, 1999 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Phase II study of gemcitabine in ovarian cancer.

von Minckwitz, G; Bauknecht, T; Visseren-Grul, C M; Neijt, J P.

Affiliation

von Minckwitz G; Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Germany.

Ann Oncol ; 10(7): 853-5, 1999 Jul.

Article in En | MEDLINE | ID: mdl-10470434

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Deoxycytidine / Antimetabolites, Antineoplastic Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Deoxycytidine / Antimetabolites, Antineoplastic Type of study: Clinical_trials Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Country of publication: